Abstract
Children with neuromuscular disorders are at high risk of intraoperative and postoperative complications. General anesthesia in these patients may exacerbate respiratory and cardiovascular failure due to a marked sensitivity to several anesthetic drugs. Moreover, succinylcholine and halogenated agents can trigger life-threatening reactions, such as malignant hyperthermia, rhabdomyolysis, and severe hyperkalemia. Therefore, regional anesthesia should be adopted whenever possible, even for children with preexisting peripheral nervous system disorders. If general anesthesia is unavoidable, special precautions must be taken, in particular for children at increased risk of respiratory complications (i.e., postoperative atelectasis, acute respiratory failure, nosocomial infections). All children with NMDs with limited respiratory reserve should be trained to use noninvasive ventilation and manual or mechanically assisted cough techniques prior to surgery and should be assisted with these devices during sedation and in the postoperative period. Noninvasive ventilation associated with aggressive airway clearance techniques can successfully treat upper airway obstruction, hypoventilation, and airway secretion retention, avoiding prolonged intubation and tracheotomy. Succinylcholine must be avoided in all NMDs except in children with neuromuscular junction diseases. Halogenated agents must be avoided in all children with muscle disease except in patients with mitochondrial myopathies.
This chapter describes anesthestetic and perioperative management of children with neuromuscular disorders.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Racca F, Mongini T, Wolfler A et al (2013) Recommendations for Anesthesia and Perioperative management of patients with neuromuscular disorders. Minerva Anestesiol 79:419–433
Birnkrant DJ (2009) The American College of Chest Physicians consensus statement on the respiratory and related management of patients with Duchenne muscular dystrophy undergoing anesthesia or sedation. Pediatrics 123(Suppl 4):S242–S244
Birnkrant DJ, Panitch HB, Benditt JO, Boitano LJ, Carter ER, Cwik VA et al (2007) American College of Chest Physicians consensus statement on the respiratory and related management of patients with Duchenne muscular dystrophy undergoing anesthesia or sedation. Chest 132(6):1977–1986
Bushby K, Finkel R, Birnkrant DJ, Case LE, Clemens PR, Cripe L et al (2010) Diagnosis and management of Duchenne muscular dystrophy, part 2: implementation of multidisciplinary care. Lancet Neurol 9(2):177–189
Wang CH, Bonnemann CG, Rutkowski A, Sejersen T, Bellini J, Battista V et al (2010) Consensus statement on standard of care for congenital muscular dystrophies. J Child Neurol 25(12):1559–1581
Wang CH, Finkel RS, Bertini ES, Schroth M, Simonds A, Wong B et al (2007) Consensus statement for standard of care in spinal muscular atrophy. J Child Neurol 22(8):1027–1049
Gozal D (2000) Pulmonary manifestations of neuromuscular disease with special reference to Duchenne muscular dystrophy and spinal muscular atrophy. Pediatr Pulmonol 29(2):141–150
Schmitt HJ, Muenster T (2009) Anesthesia in patients with neuromuscular disorders. Minerva Anestesiol 75(11):632–637
Veyckemans F (2010) Can inhalation agents be used in the presence of a child with myopathy? Curr Opin Anaesthesiol 23(3):348–355
Wappler F (2010) Anesthesia for patients with a history of malignant hyperthermia. Curr Opin Anaesthesiol 23(3):417–422
Gurnaney H, Brown A, Litman RS (2009) Malignant hyperthermia and muscular dystrophies. Anesth Analg 109(4):1043–1048
Hayes J, Veyckemans F, Bissonnette B (2008) Duchenne muscular dystrophy: an old anesthesia problem revisited. Paediatr Anaesth 18(2):100–106
Klingler W, Lehmann-Horn F, Jurkat-Rott K (2005) Complications of anaesthesia in neuromuscular disorders. Neuromuscul Disord 15(3):195–206
Driessen JJ (2008) Neuromuscular and mitochondrial disorders: what is relevant to the anaesthesiologist? Curr Opin Anaesthesiol 21(3):350–355
Graham RJ, Athiraman U, Laubach AE, Sethna NF (2009) Anesthesia and perioperative medical management of children with spinal muscular atrophy. Paediatr Anaesth 19(11):1054–1063
Birnkrant DJ (2006) New challenges in the management of prolonged survivors of pediatric neuromuscular diseases: a pulmonologist’s perspective. Pediatr Pulmonol 41(12):1113–1117
Racca F, Del Sorbo L, Mongini T, Vianello A, Ranieri VM (2010) Respiratory management of acute respiratory failure in neuromuscular diseases. Minerva Anestesiol 76(1):51–62
Rubino FA (2004) Perioperative management of patients with neurologic disease. Neurol Clin 22(2):V, 261–V, 276
Blichfeldt-Lauridsen L, Hansen BD (2012) Anesthesia and myasthenia gravis. Acta Anaesthesiol Scand 56(1):17–22
Bach JR, Goncalves MR, Hamdani I, Winck JC (2010) Extubation of patients with neuromuscular weakness: a new management paradigm. Chest 137(5):1033–1039
Vianello A, Arcaro G, Braccioni F, Gallan F, Marchi MR, Chizio S et al (2011) Prevention of extubation failure in high-risk patients with neuromuscular disease. J Crit Care 26(5):517–524
Bushby K, Finkel R, Birnkrant DJ, Case LE, Clemens PR, Cripe L et al (2010) Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management. Lancet Neurol 9(1):77–93
Hopkins PM (2010) Anaesthesia and the sex-linked dystrophies: between a rock and a hard place. Br J Anaesth 104(4):397–400
Muenster T, Mueller C, Forst J, Huber H, Schmitt HJ (2012) Anaesthetic management in patients with Duchenne muscular dystrophy undergoing orthopaedic surgery: a review of 232 cases. Eur J Anaesthesiol 29(10):489–494
Salem M, Tainsh RE Jr, Bromberg J, Loriaux DL, Chernow B (1994) Perioperative glucocorticoid coverage. A reassessment 42 years after emergence of a problem. Ann Surg 219(4):416–425
Hammond K, Margolin DA, Beck DE, Timmcke AE, Hicks TC, Whitlow CB (2010) Variations in perioperative steroid management among surgical subspecialists. Am Surg 76(12):1363–1367
Marik PE, Varon J (2008) Requirement of perioperative stress doses of corticosteroids: a systematic review of the literature. Arch Surg 143(12):1222–1226
Yong SL, Marik P, Esposito M, Coulthard P (2009) Supplemental perioperative steroids for surgical patients with adrenal insufficiency. Cochrane Database Syst Rev (4):CD005367
Frova G, Guarino A, Petrini F, Merli G, Sorbello M, Baroncini S et al (2006) Recommendations for airway control and difficult airway management in paediatric patients. Minerva Anestesiol 72(9):723–748
Keyes LE, Frazee BW, Snoey ER, Simon BC, Christy D (1999) Ultrasound-guided brachial and basilic vein cannulation in emergency department patients with difficult intravenous access. Ann Emerg Med 34(6):711–714
Troianos CA, Hartman GS, Glas KE, Skubas NJ, Eberhardt RT, Walker JD et al (2012) Special articles: guidelines for performing ultrasound guided vascular cannulation: recommendations of the American Society of Echocardiography and the Society of Cardiovascular Anesthesiologists. Anesth Analg 114(1):46–72
Sofocleous CT, Schur I, Cooper SG, Quintas JC, Brody L, Shelin R (1998) Sonographically guided placement of peripherally inserted central venous catheters: review of 355 procedures. AJR Am J Roentgenol 170(6):1613–1616
Sinclair JL, Reed PW (2009) Risk factors for perioperative adverse events in children with myotonic dystrophy. Paediatr Anaesth 19(8):740–747
Cardone A, Congedo E, Aceto P, Sicuranza R, Chine E, Caliandro F et al (2007) Perioperative evaluation of myasthenia gravis. Ann Ital Chir 78(5):359–365
Dillon FX (2004) Anesthesia issues in the perioperative management of myasthenia gravis. Semin Neurol 24(1):83–94
Shipton EA, Prosser DO (2004) Mitochondrial myopathies and anaesthesia. Eur J Anaesthesiol 21(3):173–178
Yemen TA, McClain C (2006) Muscular dystrophy, anesthesia and the safety of inhalational agents revisited; again. Paediatr Anaesth 16(2):105–108
Malviya S, Voepel-Lewis T, Tait AR, Watcha MF, Sadhasivam S, Friesen RH (2007) Effect of age and sedative agent on the accuracy of bispectral index in detecting depth of sedation in children. Pediatrics 120(3):e461–e470
De Boer HD, van Esmond J, Booij LH, Driessen JJ (2009) Reversal of rocuronium-induced profound neuromuscular block by sugammadex in Duchenne muscular dystrophy. Paediatr Anaesth 19(12):1226–1228
Unterbuchner C, Fink H, Blobner M (2010) The use of sugammadex in a patient with myasthenia gravis. Anaesthesia 65(3):302–305
Walker KJ, McGrattan K, Aas-Eng K, Smith AF (2009) Ultrasound guidance for peripheral nerve blockade. Cochrane Database Syst Rev (4):CD006459
Allison KR (2007) Muscular dystrophy versus mitochondrial myopathy: the dilemma of the undiagnosed hypotonic child. Paediatr Anaesth 17(1):1–6
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Racca, F., Robba, C. (2016). Perioperative Care of Children with Neuromuscular Disease. In: Astuto, M., Ingelmo, P. (eds) Perioperative Medicine in Pediatric Anesthesia. Anesthesia, Intensive Care and Pain in Neonates and Children. Springer, Cham. https://doi.org/10.1007/978-3-319-21960-8_12
Download citation
DOI: https://doi.org/10.1007/978-3-319-21960-8_12
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-21959-2
Online ISBN: 978-3-319-21960-8
eBook Packages: MedicineMedicine (R0)